Home > Healthcare > Biotechnology > Biotechnology R&D > Protein Labeling Market

Protein Labeling Market Trends

Report ID: GMI6494
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Protein Labeling Market Trends

The increasing investment in research and development dedicated to proteomics research has significantly amplified the demand for protein labeling solutions. It enables to study the complexities of protein activities, relationships, and expression patterns. With an intensified focus on unravelling the complexities of proteomics, the precision and versatility offered by protein labeling methods have become indispensable tools. This heightened investment has catalysed the advancement of labeling technologies, leading to innovations such as site-specific and bioorthogonal labeling, that enhance accuracy and customization.

Also, the symbiotic relationship between increased R&D expenditure in proteomics research and the sophistication of protein labeling techniques has propelled the field in terms of expediting discoveries and applications across disease diagnostics, drug development, and personalized medicine, thereby fostering the market trends.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Protein labeling industry was worth USD 2.2 billion in 2022 and is estimated to expand at 10.6% CAGR from 2023-2032 driven by the increasing advancements in molecular biology along with rising biopharmaceutical research, drug development, and diagnostics.

The kits & reagents segment accounted for 69.3% of the market share in 2022 and is projected to expand substantially through 2032 owing to their rising need for streamlined solution for researchers.

North America held 42.8% share of the protein labeling market in 2022 and is anticipated to grow at considerable CAGR through 2032 driven by the increasing R&D investments for drug discovery, personalized medicine, and disease diagnostics in the region.

Some of the top firms operating in the market are Thermo Fisher Scientific Inc., Merck & Co., Inc, F. Hoffmann-La Roche, Promega Corporation, Bio-Rad Laboratories among others.